| Product Code: ETC7181379 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Non-steroidal Anti-inflammatory Drugs Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle |
3.4 Fiji Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces |
3.5 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Fiji Non-steroidal Anti-inflammatory Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory diseases in Fiji |
4.2.2 Growing geriatric population in Fiji |
4.2.3 Rising awareness about the benefits of non-steroidal anti-inflammatory drugs |
4.2.4 Increasing disposable income leading to higher healthcare spending |
4.2.5 Government initiatives to improve healthcare infrastructure and access to medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and distribution |
4.3.2 Potential side effects associated with non-steroidal anti-inflammatory drugs |
4.3.3 Competition from alternative treatment options such as natural remedies or physical therapy |
4.3.4 Price fluctuations of raw materials used in drug manufacturing |
4.3.5 Limited availability of specialized healthcare professionals for prescribing these drugs |
5 Fiji Non-steroidal Anti-inflammatory Drugs Market Trends |
6 Fiji Non-steroidal Anti-inflammatory Drugs Market, By Types |
6.1 Fiji Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.1.4 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.1.5 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.2 Fiji Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.2.3 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F |
6.2.4 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F |
6.2.5 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Fiji Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Fiji Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics |
7.1 Fiji Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries |
7.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries |
8 Fiji Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for non-steroidal anti-inflammatory drugs |
8.2 Patient adherence rate to non-steroidal anti-inflammatory drug treatment |
8.3 Average waiting time at pharmacies for non-steroidal anti-inflammatory drugs |
8.4 Patient satisfaction with the efficacy of non-steroidal anti-inflammatory drugs |
8.5 Rate of adverse events reported related to non-steroidal anti-inflammatory drug usage |
9 Fiji Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment |
9.1 Fiji Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Fiji Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Fiji Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape |
10.1 Fiji Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024 |
10.2 Fiji Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |